Ronit Simantov
Chief Tech/Sci/R&D Officer at GAMIDA CELL LTD.
Net worth: 9 227 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Julian Adams | M | 69 | 8 years | |
| Stephen Brady | M | 54 | 5 years | |
| Mike Raab Raab | M | 59 |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 6 years |
| Justin Trojanowski | M | 36 | 2 years | |
| Geoffrey Nichol | M | 69 |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 5 years |
| Thomas Woiwode | M | 52 |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 6 years |
| Shawn Tomasello | F | 65 | 5 years | |
| Christine Pellizzari | F | 56 |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 3 years |
| Darrin Bomba | M | - |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | 3 years |
| Nicholas Maestas | M | 44 | 3 years | |
| Ivan Borrello | M | 60 | 2 years | |
| Mary Coelho | F | 62 | 1 years | |
| Joseph Echevarria | M | 66 | 9 years | |
| Stephen Wills | M | 67 | 5 years | |
| Jim Smith | M | 64 | 10 years | |
| Sharon Sakai | M | - | - | |
| Kenneth Moch | M | 69 | 8 years | |
| Shantanu Narayen | M | 60 | 11 years | |
| Ronald Blaylock | M | 64 | 7 years | |
| Helen Hobbs | M | 71 | 13 years | |
| Yisrael Gewirtz | M | 47 | - | |
| Sam Whiting | M | 58 | 4 years | |
| Vladimir Melnikov | M | - | 3 years | |
| Steve Danehy | M | - | 12 years | |
| Bryan Supran | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Steere | M | 87 | 28 years | |
| Patrick Mahaffy | M | 61 | 14 years | |
| Joshua D. Hamermesh | M | 51 | - | |
| Yael Margolin | M | 70 | 14 years | |
| Pierre Lorenzo | M | - | - | |
| Heather DiVecchia | F | - | 6 years | |
| Ginger Graham | F | 68 | 10 years | |
| George A. Lorch | M | 82 | 15 years | |
| Paul Gross | M | 59 | 7 years | |
| Abbey Jenkins | F | - | - | |
| Amy Schulman | F | 63 | 6 years | |
| Yi Ning Zhao | M | 53 | 8 years | |
| Robert Azelby | M | 56 | 5 years | |
| Robert Landry | M | 60 | 4 years | |
| Thomas Dubensky | M | 66 | 6 years | |
| Marc Tessier-Lavigne | M | 64 | 4 years | |
| Boaz Lifschitz | M | 55 | 5 years | |
| Ofer Gonen | M | 49 | 7 years | |
| Shai Lankry | M | 47 | 5 years | |
| Breanna Burkart | F | - | 14 years | |
| Jaren Madden | F | - | - | |
| Lindsey Rolfe | M | 56 | 13 years | |
| Richard Fair | M | 55 | 5 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Keith Flaherty | M | 53 | 10 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| John Mascotte | M | 84 | 4 years | |
| Joshua Patterson | M | 48 | 3 years | |
| Paul Klingenstein | M | 68 | 14 years | |
| Elizabeth A. Whayland | F | 63 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | 14 years |
| Daniel Muehl | M | 61 | 8 years | |
| Edward McKinley | M | 72 | 14 years | |
| Robert N. Burt | M | 86 | 11 years | |
| William Herbert Gray | M | 82 | 13 years | |
| M. Anthony Burns | M | 81 | 25 years | |
| David Wurzer | M | 65 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | 10 years |
| Michael Brown | M | 83 | 16 years | |
| James Blair | M | 84 | 14 years | |
| Tzvi Palash | M | 67 | 3 years | |
| Brian Atwood | M | 71 | 14 years | |
| Michael Perry | M | 64 | 4 years | |
| Thorlef Spickschen | M | 83 | 14 years | |
| David Fox | M | 66 | 1 years | |
| Nurit Benjamini | F | 57 | 2 years | |
| Jeremy Blank | M | 45 | - | |
| Margaret Marshall | M | 67 | 8 years | |
| James Wassil | M | 54 | 4 years | |
| Soma Gupta | F | - | 6 years | |
| Reina Benabou | M | 60 | 4 years | |
| Hong I. Wan | M | - | 5 years | |
| Paulash Mohsen | M | - | 14 years | |
| David Hering | M | 49 | 6 years | |
| Richard Margolin | M | 73 | 2 years | |
| Clare Khan | M | 72 | 6 years | |
| Adrian Woolfson | M | 60 | 3 years | |
| Javier Cote-Sierra | M | 61 | 2 years | |
| Premal Patel | M | 54 | 2 years | |
| Beth Calitri | F | - | 2 years | |
| Ian Taylor | M | 61 | 9 years | |
| Anna Berkenblit | M | 54 | 4 years | |
| Vatnak Vat-Ho | M | - | 4 years | |
| Torben Nissen | M | 53 | 2 years | |
| John Hubbard | M | 67 | 5 years | |
| Martine George | M | 76 | 5 years | |
| Edmund Harrigan | M | 71 | 12 years | |
| Christine Regan Lindenboom | F | 43 | - | |
| Valerie Start | M | 64 | 3 years | |
| Susan E. Ward | M | - | 2 years | |
| Cara Cassino | M | 62 | 5 years | |
| Baiyong Li | M | 56 | 12 years | |
| Feng Guo | M | 54 | 11 years | |
| Carl Morris | M | 54 | 5 years | |
| William S. Korinek | M | - | 9 years | |
| Xu Guang Ma | M | 53 |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | 8 years |
| Iain Kilty | M | - | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 78 | 78.00% |
| Israel | 22 | 22.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronit Simantov
- Personal Network
